Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Levamisol hydrochloride

EU orphan designation number: EU/3/05/324   
Active ingredient: Levamisol hydrochloride
Indication: Treatment of nephrotic syndrome
Sponsor: ACE Pharmaceuticals BV
Schepenveld 41, 3891 ZK Zeewolde, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/11/2005 Orphan designation EMEA/OD/058/05 (2005)4342 of 28/10/2005